Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.

ABSTRACT:

Background

While lung transplant (LTX) can be an effective therapy to provide the survival benefit in selected populations, post-transplant outcome in LTX recipients with bronchiectasis other than cystic fibrosis (CF) has been less studied. Pseudomonas aeruginosa, often associated with exacerbations in bronchiectasis, is the most common micro-organism isolated from LTX recipients. We aimed to see the outcomes of patients with bronchiectasis other than CF after LTX and seek the risk factors associated with pre- and post-transplant Pseudomonas status.

Methods

Patients who underwent LTX at Tohoku University Hospital between January 2000 and December 2020 were consecutively included into the retrospective cohort study. Pre- and post-transplant prevalence of Pseudomonas colonizat

SUBMITTER: Hirama T 

PROVIDER: S-EPMC8361737 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature